Puma Biotechnology(PBYI) - 2023 Q2 - Earnings Call Presentation

Puma Biotechnology Earnings Call Commercial Update Forward-Looking Safe-Harbor Statement Puma's Pharmacy and Distributor Network Copyright 2023 Puma Biotechnology 3 Q2'22 Q2'23 + $2.7 mil - $1.5 mil August 3, 2023 This presentation contains forward-looking statements, including statements regarding commercialization of NERLYNX® and the potential indications and development of our drug candidates. All forward-looking statements involve risks and uncertainties that could cause our actual results to differ mat ...